01/08/2026
“This would’ve sounded like science fiction a few years ago. Today, AI is compressing timelines, reshaping decision-making, and moving us from drug discovery toward true drug design. The real question isn’t whether AI is changing the field; it’s what breakthroughs come next.” – Eric Weisberg, Global Chief Creative Officer, Havas Health
Today on the CES 2026 mainstage, Eric was joined by Dr. Laura Matz, Gerry Keane, and Jen Hoskins for “Drug Discovery Disrupted: Tech That’s Changing the Game”—a thoughtful conversation about how AI, data, and computation are reshaping modern drug discovery, from early-stage science to real patient impact.
Thank you to this incredible group of panelists for a compelling, forward-looking discussion.
hashtag hashtag hashtag | | |